| P50 | author | Lori B Tucker | Q40207671 |
| | Kelly L Brown | Q49631205 |
| P2093 | author name string | Clara Westwell-Roper | |
| | Iwona Niemietz | |
| P2860 | cites work | Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations | Q24300638 |
| | Update on Pyrin Functions and Mechanisms of Familial Mediterranean Fever | Q26749573 |
| | EULAR recommendations for the management of familial Mediterranean fever | Q26775286 |
| | Predominant role of host genetics in controlling the composition of gut microbiota | Q33363139 |
| | Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever | Q33742607 |
| | Analysis of MEFV exon methylation and expression patterns in familial Mediterranean fever | Q33984080 |
| | Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever | Q34146734 |
| | An international registry on autoinflammatory diseases: the Eurofever experience | Q34257724 |
| | The spectrum of Familial Mediterranean Fever (FMF) mutations | Q34314032 |
| | Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice | Q35086225 |
| | Familial Mediterranean fever without MEFV mutations: a case-control study | Q35225591 |
| | E148Q is a disease-causing MEFV mutation: a phenotypic evaluation in patients with familial Mediterranean fever | Q35555482 |
| | Severe disease in patients with rheumatoid arthritis carrying a mutation in the Mediterranean fever gene | Q35555791 |
| | Analysis of the genetic basis of periodic fever with aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome. | Q35623377 |
| | Association between MEFV Mutations M694V and M680I and Behçet's Disease: A Meta-Analysis | Q35692083 |
| | Guidelines for the genetic diagnosis of hereditary recurrent fevers. | Q36406233 |
| | Familial Mediterranean fever with a single MEFV mutation: where is the second hit? | Q37366257 |
| | Familial mediterranean Fever in the world | Q37605663 |
| | Anti-TNF agents in familial Mediterranean fever: report of three cases and review of the literature. | Q37874985 |
| | A clinical guide to autoinflammatory diseases: familial Mediterranean fever and next-of-kin | Q38163822 |
| | The E148Q mutation in the MEFV gene: is it a disease-causing mutation or a sequence variant? | Q38902787 |
| | The differential contribution of MEFV mutant alleles to the clinical profile of familial Mediterranean fever. | Q39021036 |
| | Colchicine resistance and intolerance in familial mediterranean fever: Definition, causes, and alternative treatments | Q39245123 |
| | Monogenic Periodic Fever Syndromes: Treatment Options for the Pediatric Patient | Q39301708 |
| | The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation | Q39443996 |
| | MEFV mutations and their relation to major clinical symptoms of Familial Mediterranean Fever | Q40057875 |
| | Tofacitinib suppresses disease activity and febrile attacks in a patient with coexisting rheumatoid arthritis and familial Mediterranean fever | Q40062696 |
| | Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled Trial | Q40079604 |
| | Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers | Q40171678 |
| | MEFV gene mutations in Henoch-Schönlein purpura | Q40236767 |
| | Increased NLRP3-dependent interleukin 1β secretion in patients with familial Mediterranean fever: correlation with MEFV genotype | Q40254261 |
| | Results from a multicentre international registry of familial Mediterranean fever: impact of environment on the expression of a monogenic disease in children | Q40255424 |
| | Association of the MEFV gene variations with inflammatory bowel disease in Turkey | Q40280186 |
| | NOD2/CARD15 gene mutations in patients with familial Mediterranean fever | Q40299234 |
| | The relative contribution of environmental and genetic factors to phenotypic variation in familial Mediterranean fever (FMF). | Q40308353 |
| | The Familial Mediterranean Fever Gene as a Modifier of Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenopathy Syndrome | Q40348928 |
| | Role of the R92Q TNFRSF1A mutation in patients with familial Mediterranean fever | Q40357744 |
| | A new set of criteria for the diagnosis of familial Mediterranean fever in childhood | Q40397895 |
| | MEFV mutations in systemic onset juvenile idiopathic arthritis | Q40405557 |
| | Prevalence of the MEFV gene mutations in childhood polyarteritis nodosa | Q40433800 |
| | The rate of pyrin mutations in critically ill patients with systemic inflammatory response syndrome and sepsis: a pilot study. | Q40442030 |
| | Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. | Q40451318 |
| | The familial Mediterranean fever (MEVF) gene as a modifier of Crohn's disease | Q40516407 |
| | Common mutations in the familial Mediterranean fever gene associate with rapid progression to disability in non-Ashkenazi Jewish multiple sclerosis patients | Q40561053 |
| | Criteria for the diagnosis of familial Mediterranean fever | Q40645936 |
| | Longitudinal analysis of serum interleukin-18 in patients with familial Mediterranean fever carrying MEFV mutations in exon 10. | Q41922325 |
| | A Nationwide Experience With The Off-label Use of Interleukin-1 Targeting Treatment in Familial Mediterranean Fever Patients. | Q41927574 |
| | The spectrum of Familial Mediterranean Fever gene (MEFV) mutations and genotypes in Iran, and report of a novel missense variant (R204H). | Q41929078 |
| | Recommendations for collaborative paediatric research including biobanking in Europe: a Single Hub and Access point for paediatric Rheumatology in Europe (SHARE) initiative | Q42696379 |
| | Coexistent MEFV and CIAS1 mutations manifesting as familial Mediterranean fever plus deafness | Q42753824 |
| | Refractory auto-inflammatory syndrome associated with digenic transmission of low-penetrance tumour necrosis factor receptor-associated periodic syndrome and cryopyrin-associated periodic syndrome mutations | Q42955426 |
| | Comparison of early versus late onset familial Mediterranean fever. | Q47191005 |
| | Alteration of the microRNA expression profile in familial Mediterranean fever patients | Q47336099 |
| | Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the Pyrin inflammasome. | Q47638843 |
| | Lack of clear and univocal genotype-phenotype correlation in Familial Mediterranean Fever patients: A systematic review | Q48114554 |
| | Evidence for genetic overlap between adult onset Still's disease and hereditary periodic fever syndromes | Q48266470 |
| | Evaluation of the effects of miRNAs in familial Mediterranean fever | Q50016519 |
| | Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes. | Q53818566 |
| | Analysis of microRNAs in familial Mediterranean fever. | Q55301278 |
| | TNF/TNFR axis promotes pyrin inflammasome activation and distinctly modulates pyrin inflammasomopathy | Q63976848 |
| | Update on the epidemiology and disease outcome of Familial Mediterranean fever | Q90346728 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatology | Q327657 |
| | pyrin | Q41796763 |
| | Genetic Association Studies | Q57418291 |
| P304 | page(s) | 22 | |
| P577 | publication date | 2019-05-14 | |
| P1433 | published in | Pediatric Rheumatology Online Journal | Q15756119 |
| P1476 | title | Periodic fever syndromes: beyond the single gene paradigm | |
| P478 | volume | 17 | |